Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
Author(s) -
JyhMing Liou,
ChiehChang Chen,
ChungYu Chang,
MeiJyh Chen,
Y.-J. Fang,
Jung Yeon Lee,
ShihJer Hsu,
YaoChun Hsu,
Cheng-Hao Tseng,
PingHuei Tseng,
Lin Chang,
Wen Chang,
ChihHsien Wang,
ChiaTung Shun,
J.-Y. Wu,
YiChia Lee,
J.-T. Lin,
Ming–Shiang Wu
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks407
Subject(s) - levofloxacin , esomeprazole , clarithromycin , medicine , helicobacter pylori , amoxicillin , gastroenterology , metronidazole , agar dilution , drug resistance , intention to treat analysis , antibiotics , randomized controlled trial , microbiology and biotechnology , biology , minimum inhibitory concentration
The efficacy of sequential therapy and the applicability of genotypic resistance to guide the selection of antibiotics in the third-line treatment of Helicobacter pylori have not been reported. We aimed to assess the efficacy of genotypic resistance-guided sequential therapy in third-line treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom